Stockreport

CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation

CareDx, Inc.  (CDNA) 
Last caredx, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.caredxinc.com
PDF KOAR, the Largest Prospective Study of Its Kind, Demonstrates Clinical Utility of AlloSure® in Kidney Transplant SurveillanceAlloSure Kidney dd-cfDNA Elevation Strongly [Read more]